Financial statements Bio-Systec
Balance sheet data of BIO-SYSTEC
|
Year
|
2018
|
2019
|
2020
|
|---|---|---|---|
| Total assets | 5 648 740,06 | 4 649 470,40 | 4 276 096,88 |
| A. Fixed assets | 139 600,00 | 139 600,00 | 139 600,00 |
| B. Current assets | 5 509 140,06 | 4 509 870,40 | 4 136 496,88 |
| C. Share capital contributions (basic funds) | - | - | - |
| D. Own shares (stocks) | - | - | - |
| Total liabilities | 5 648 740,06 | 4 649 470,40 | 4 276 096,88 |
| A. Equity | 405 377,42 | 456 970,34 | 513 254,69 |
| B. Liabilities and provisions for liabilities | 5 243 362,64 | 4 192 500,06 | 3 762 842,19 |
| I. Long-term liabilities | - | - | - |
| II. Short-term liabilities | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.